Kestra Medical Technologies, Ltd. (KMTS) stock
Close on Nov 17, 2026Market cap $1.68BP/E –Yield –
Earnings
Kestra Medical Technologies's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Kestra Medical Technologies's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q2 FY2027ended Oct 31, 2026 | Dec 10, 2026Expected | – | – | – | – |
| Q1 FY2027ended Jul 31, 2026 | Sep 14, 2026after the close | $31.00M | +59.8% | – | Release |
| Q4 FY2026ended Apr 30, 2026 | Jul 14, 2026after the close | $28.60M | +66.3% | – | Release |
| Q3 FY2026ended Jan 31, 2026 | Mar 17, 2026after the close | $24.60M | +62.9% | -$0.61 | Release |
| Q2 FY2026ended Oct 31, 2025 | Dec 11, 2025after the close | $22.60M | – | -$0.64 | Release |
| Q1 FY2026ended Jul 31, 2025 | Sep 11, 2025after the close | $19.40M | – | – | Release |
| Q4 FY2025ended Apr 30, 2025 | Jul 15, 2025after the close | $17.20M | – | – | Release |
| Q3 FY2025ended Jan 31, 2025 | Apr 14, 2025after the close | $15.10M | – | -$1.25 | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Kestra Medical Technologies's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| growth | FY2027 | +48% | – | New | Sep 14, 2026 |
| revenue guidance | FY2027 | $141.00M | $137.00M | Raised | Sep 14, 2026 |
Guidance vs results
The last range Kestra Medical Technologies gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2026 | Revenue | $93.00M | $95.20MΣ4Q | Above range |
Guidance history
Every forecast Kestra Medical Technologies put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Sep 14, 2026 | revenue guidance | FY2027 | $141.00M | Raised |
| Sep 14, 2026 | growth | FY2027 | +48% | New |
| Jul 14, 2026 | revenue | FY2027 | $137.00M | New |
| Mar 17, 2026 | revenue guidance | FY2026 | $93.00M | Raised |
| Dec 11, 2025 | revenue | FY2026 | $91.00M | New |
| Sep 11, 2025 | revenue guidance | FY2026 | $88.00M | Raised |
| Jul 15, 2025 | revenue | FY2026 | $85.00M | New |
| Apr 14, 2025 | revenue | FY2025 | $58.00M – $58.50M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Kestra Medical Technologies filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Results
See a number that looks wrong?